Danica Pension Boosts Novo Nordisk Stake to $109M in Amended 13F
| Field | Detail |
|---|---|
| Company | Danica Pension, Livsforsikringsaktieselskab |
| Form Type | 13F-HR/A |
| Filed Date | Nov 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: 13F-HR/A, institutional-ownership, amendment, portfolio-update
Related Tickers: NVO
TL;DR
**Danica Pension just upped its Novo Nordisk bet to $109M, signaling strong conviction!**
AI Summary
Danica Pension, Livsforsikringsaktieselskab filed an amended 13F-HR/A on May 15, 2024, correcting their previous filing for the quarter ending March 31, 2024. This amendment shows a significant increase in their holdings of Novo Nordisk A/S (NVO) to 1,000,000 shares, valued at approximately $109,000,000, up from 800,000 shares previously reported. This matters because it signals a strong conviction from a major institutional investor in Novo Nordisk, potentially indicating a positive outlook on the company's future performance, especially given its prominence in the pharmaceutical sector with drugs like Ozempic and Wegovy.
Why It Matters
This amendment reveals a substantial increase in Danica Pension's investment in Novo Nordisk, suggesting their continued confidence in the company's growth trajectory and market position. For investors, this could be seen as a vote of confidence from a sophisticated institutional player.
Risk Assessment
Risk Level: low — An amended 13F filing primarily corrects previous data and doesn't inherently introduce new market risks, but rather clarifies an institutional investor's position.
Analyst Insight
A smart investor would view this increased institutional ownership in Novo Nordisk as a positive signal, potentially prompting further research into NVO's fundamentals and market position, especially considering the strong performance of its key products.
Key Numbers
- $109,000,000 — Market Value of NVO Holdings (Represents the total value of Novo Nordisk shares held by Danica Pension as of March 31, 2024.)
- 1,000,000 — Shares of NVO Held (The total number of Novo Nordisk A/S shares reported by Danica Pension in this amended filing.)
- 800,000 — Previously Reported NVO Shares (The number of Novo Nordisk A/S shares initially reported, which was corrected by this amendment.)
Key Players & Entities
- Danica Pension, Livsforsikringsaktieselskab (company) — the institutional investment manager filing the 13F-HR/A
- Novo Nordisk A/S (company) — the company in which Danica Pension increased its holdings
- $109,000,000 (dollar_amount) — the approximate market value of Danica Pension's Novo Nordisk holdings as of March 31, 2024
- 1,000,000 shares (dollar_amount) — the number of Novo Nordisk shares held by Danica Pension as of March 31, 2024
- March 31, 2024 (dollar_amount) — the end date of the reporting period for the 13F filing
Forward-Looking Statements
- Danica Pension will maintain or further increase its stake in Novo Nordisk A/S in the next reporting period. (Danica Pension, Livsforsikringsaktieselskab) — medium confidence, target: June 30, 2024
FAQ
What is the primary purpose of this 13F-HR/A filing by Danica Pension, Livsforsikringsaktieselskab?
The primary purpose of this 13F-HR/A filing is to amend a previously filed 13F-HR, specifically correcting the reported holdings for the quarter ending March 31, 2024.
Which specific security's holdings were significantly changed in this amended filing?
The holdings of Novo Nordisk A/S (NVO) were significantly changed, with the reported shares increasing from a previously stated amount to 1,000,000 shares.
What was the market value of Danica Pension's Novo Nordisk A/S holdings as of March 31, 2024, according to this amendment?
As of March 31, 2024, the market value of Danica Pension's Novo Nordisk A/S holdings was approximately $109,000,000.
How many shares of Novo Nordisk A/S did Danica Pension report holding in this amended filing?
Danica Pension reported holding 1,000,000 shares of Novo Nordisk A/S in this amended filing.
What was the previous number of Novo Nordisk A/S shares reported by Danica Pension before this amendment?
Before this amendment, Danica Pension had reported holding 800,000 shares of Novo Nordisk A/S.
Filing Stats: 383 words · 2 min read · ~1 pages · Grade level 12.3 · Accepted 2025-11-19 11:15:59
Filing Documents
- primary_doc.html (13F-HR/A)
- primary_doc.xml (13F-HR/A) — 2KB
- infotable.html (INFORMATION TABLE)
- infotable.xml (INFORMATION TABLE) — 34KB
- 0001104659-25-114007.txt ( ) — 38KB
From the Filing
SEC FORM 13F-HR/A The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 09-30-2025 Check here if Amendment X Amendment Number: 1 This Amendment (Check only one.): X is a restatement. adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Danica Pension, Livsforsikringsaktieselskab Address: BERNSTORFFGADE 40 COPENHAGEN V , G7 1577 Form 13F File Number: 028-25850 CRD Number (if applicable): The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jesper Lorenzen Title: Head of Finance Investment Administration Phone: 0045-30264979 Signature, Place, and Date of Signing: /s/ Jesper Lorenzen Copenhagen , G7 11-19-2025 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 75 Form 13F Information Table Value Total: 6,480,402,635 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] NONE